Aurobindo Pharma received 46th ANDA approval from USFDA for Terbinafine HCL Tablets

Aurobindo Pharma Ltd has announced that the Company has received approval from the USFDA for Terbinafine Hydrochloride Tablets 250 mg. This approval is received on the first day after the expiry of the relevant patent.

Terbinafine Hydrochloride Tablets 250 mg are the Generic equivalent of Novartis anti fungal Lamisil® Tablets. The brand product has annual sales of approximately USD 654 million in US.

The stock closed the day at Rs.774.45, down by Rs.12.75 or 1.62%. The stock hit an intraday high of Rs.799.95 and low of Rs.770. The total traded quantity was 62246 compared to 2 week average of 68538.

Source : Equity Bulls

Keywords